Sarepta Therapeutics Inc (SRPT)
123.37
+1.47
(+1.21%)
USD |
NASDAQ |
Dec 26, 16:00
123.95
+0.58
(+0.47%)
After-Hours: 20:00
Sarepta Therapeutics Gross Profit (Annual): 1.093B for Dec. 31, 2023
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
Arrowhead Pharmaceuticals Inc | -- |
Eli Lilly and Co | 27.04B |
Alnylam Pharmaceuticals Inc | 1.518B |
Catalyst Pharmaceuticals Inc | 346.24M |
Vertex Pharmaceuticals Inc | 8.607B |